A trial of pulsed xenon ultraviolet disinfection to reduce Clostridioides difficile infection - 30/03/19
, Carla Folkert, MBA ⁎, Jean E. Barth, MPH, RN, CIC ⁎, Larry Nation, MA ⁎, Michel Benz, MSN, RN ⁎, Allison Hesse, MS, RN, Catherine L. Mielke MS,, APRN, Kathryn W. Zaveleta, MHSARésumé |
Background |
An intervention was designed to test whether the addition of an ultraviolet (UV) disinfection step after terminal cleaning would be helpful in reducing Clostridium difficile infection (CDI) rates in a real-world situation.
Methods |
This study was a quasi-experimental design using 3 units as intervention units for the intervention and 3 similar units as control units. Intervention units 2 hematology and bone marrow transplant units and one medical-surgical unit at a large teaching hospital in the Midwest. UV disinfection was added after patient discharge and terminal cleaning in the intervention units.
Results |
At baseline, CDI rates in the intervention and control arms were similar. During the 6 months of UV disinfection, the CDI rate in the intervention units decreased to 11.2 per 10,000 patient days, compared with 28.7 per 10,000 patient days in the control units (P = .03). In addition, the intervention units also saw a reduction in vancomycin-resistant enterococci acquisition.
Conclusions |
The addition of UV disinfection to the terminal cleaning resulted in a reduction in CDI that has been sustained over several months 2 years.
Le texte complet de cet article est disponible en PDF.Key Words : Terminal cleaning, Environmental cleaning, Bone marrow transplant units, VRE
Plan
| Conflicts of interest: None to report. |
Vol 47 - N° 4
P. 406-408 - avril 2019 Retour au numéro
Article précédent
- Environmental services impact on healthcare–associated Clostridium difficile reduction
- Teresa Daniels, Melissa Earlywine, Vicki Breeding
- Assessment of focused multivector ultraviolet disinfection withshadowless delivery using 5-point multisided sampling ofpatientcare equipment without manual-chemical disinfection
- Donna Armellino, Thomas J. Walsh, Vidmantas Petraitis, Wladyslaw Kowalski
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?